Key result
Persistent AKI linked to ~54% higher 28-day mortality vs. no early AKI.
Why the study?
Most studies treat AKI as a static event in AMI patients, but the association of early AKI trajectories with short- and long-term mortality is unclear.
Does early persistent-pattern or transient AKI impact 28-day and 1-year mortality compared to no early AKI in critically ill patients with acute myocardial infarction?
Cohort (n=3,464)
No
Does early persistent-pattern or transient AKI impact 28-day and 1-year mortality compared to no early AKI in critically ill patients with acute myocardial infarction?
In critically ill patients with acute myocardial infarction, persistent-pattern AKI, but not transient AKI, is significantly associated with higher short- and long-term mortality.
Answers are grounded in this paper and cite their sources.
Persistent-pattern AKI may stratify mortality risk in ICU AMI patients; hypothesis-generating, requiring prospective trials before guiding care.
Background Acute kidney injury (AKI) complicating acute myocardial infarction (AMI) is associated with mortality, yet most studies treat AKI as a static event. We examined whether early AKI trajectories were associated with short- and long-term mortality among critically ill patients with AMI whose kidney status was observable from 48 to < 72 h. Methods We conducted a retrospective 72-hour landmark cohort study using MIMIC-IV v3.1. Adults admitted to an ICU during a hospitalization coded for AMI were eligible; those who died or were discharged alive by 72 h were excluded. The primary comparison further required at least one derived KDIGO-stage record from 48 to < 72 h and excluded late-onset AKI and unobservable trajectories. Recorded trajectories were classified as no early AKI, transient AKI, or persistent-pattern AKI. Outcomes were 28-day and 1-year all-cause mortality. Cox models adjusted for demographics, AMI subtype, comorbidity, non-renal SOFA, vital signs, vasoactive drug use, and invasive ventilation. Results Among 7454 eligible patients, 6274 met the landmark criteria. The primary cohort comprised 3464 patients: 422 with no early AKI, 892 with transient AKI, and 2150 with persistent-pattern AKI. Another 2810 landmark survivors had late-onset AKI ( n = 195) or unobservable trajectories ( n = 2615). Compared with no early AKI, transient AKI was not associated with 28-day mortality (hazard ratio [HR], 0.91; 95% confidence interval [CI], 0.66–1.25) or 1-year mortality (HR, 0.97; 95% CI, 0.78–1.20). Persistent-pattern AKI was associated with higher 28-day mortality (HR, 1.54; 95% CI, 1.17–2.04) and 1-year mortality (HR, 1.33; 95% CI, 1.09–1.61). In the strict ICU-through-72-hour analysis, the corresponding estimates attenuated to 1.34 (0.99–1.83) and 1.18 (0.95–1.47). The 1-year association varied over time and was concentrated early after the landmark. Conclusions Persistent-pattern AKI was associated with higher mortality in the selected subgroup with observable trajectories from 48 to < 72 h. Attenuation under stricter ICU-observation requirements and residual AMI-specific confounding limit generalizability and causal interpretation. Dynamic AKI reassessment may provide prognostic information, but these data do not show that changing an AKI trajectory improves outcomes.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) conducted a cohort in Acute myocardial infarction (n=3,464). Persistent-pattern acute kidney injury vs. No early acute kidney injury was evaluated on 28-day all-cause mortality (HR 1.54, 95% CI 1.17-2.04, p=0.002). Persistent-pattern acute kidney injury was associated with significantly higher 28-day mortality (HR 1.54) and 1-year mortality (HR 1.33) compared to no early acute kidney injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: